bimekizumab,upadacitinib
ucb pharmaceuticals,abbvie
['psoriasis', 'upadacitinib', 'bimekizumab']
the psoriasis hub will be covering the following sessions today: safety &amp; efficacy of bimekizumab in patients with active #psoriaticarthritis malignancy in upadacitinib treated pts and more! stay tuned for updates throughout the day.
#acr22 #medicalcongress #psoriasis 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education.